These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 23900693)
21. Pharmacokinetics of fleroxacin in renal impairment. Weidekamm E Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of the single-dose pharmacokinetics of bilastine in subjects with various degrees of renal insufficiency. Lasseter KC; Sologuren A; La Noce A; Dilzer SC Clin Drug Investig; 2013 Sep; 33(9):665-73. PubMed ID: 23873362 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. Borgström L; Nyberg L; Jönsson S; Lindberg C; Paulson J Br J Clin Pharmacol; 1989 Jan; 27(1):49-56. PubMed ID: 2706188 [TBL] [Abstract][Full Text] [Related]
24. The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole. Sobue S; Tan K; Layton G; Leclerc V; Weil A Br J Clin Pharmacol; 2004 Jun; 57(6):773-84. PubMed ID: 15151523 [TBL] [Abstract][Full Text] [Related]
25. A Population Pharmacokinetic Model for Kuan IHS; Duffull SB; Putt TL; Schollum JBW; Walker RJ; Wright DFB Clin Pharmacokinet; 2017 Jun; 56(6):671-678. PubMed ID: 27943221 [TBL] [Abstract][Full Text] [Related]
26. 68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: comparison to conventional 51Cr-EDTA. Hofman M; Binns D; Johnston V; Siva S; Thompson M; Eu P; Collins M; Hicks RJ J Nucl Med; 2015 Mar; 56(3):405-9. PubMed ID: 25678493 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults. Rosenborg J; Larsson P; Nyberg L Br J Clin Pharmacol; 2000 Mar; 49(3):199-206. PubMed ID: 10718774 [TBL] [Abstract][Full Text] [Related]
28. Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function. Larsson R; Karlberg BE; Gelin A; Aberg J; Regårdh CG J Clin Pharmacol; 1990 Nov; 30(11):1020-30. PubMed ID: 2243149 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke. Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600 [TBL] [Abstract][Full Text] [Related]
30. Clearance of iohexol, chromium-51-ethylenediaminetetraacetic acid, and creatinine for determining the glomerular filtration rate in pigs with normal renal function: comparison of different clearance techniques. Frennby B; Sterner G; Almén T; Chai CM; Jönsson BA; Månsson S Acad Radiol; 1996 Aug; 3(8):651-9. PubMed ID: 8796729 [TBL] [Abstract][Full Text] [Related]
31. Renal potassium handling in chronic kidney disease: Differences between patients with or wihtout hyperkalemia. Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F Nefrologia (Engl Ed); 2020; 40(2):152-159. PubMed ID: 31353054 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function. Gretler DD; Guerciolini R; Williams PJ Clin Ther; 2004 Mar; 26(3):390-8. PubMed ID: 15110131 [TBL] [Abstract][Full Text] [Related]
34. Mannitol clearance for the determination of glomerular filtration rate-a validation against clearance of Kiss K; Molnár M; Söndergaard S; Molnár G; Ricksten SE Clin Physiol Funct Imaging; 2018 Jan; 38(1):10-16. PubMed ID: 27256921 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Leroy A; Humbert G; Fillastre JP Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic Study of Intravenous Acetaminophen Administered to Critically Ill Multiple-Trauma Patients at the Usual Dosage and a New Proposal for Administration. Fuster-Lluch O; Zapater-Hernández P; Gerónimo-Pardo M J Clin Pharmacol; 2017 Oct; 57(10):1345-1352. PubMed ID: 28419483 [TBL] [Abstract][Full Text] [Related]
38. Terbutaline: level the playing field for inhaled β Jacobson GA; Hostrup M Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883 [TBL] [Abstract][Full Text] [Related]
39. Effects of varying degrees of renal impairment on the pharmacokinetics of duloxetine: analysis of a single-dose phase I study and pooled steady-state data from phase II/III trials. Lobo ED; Heathman M; Kuan HY; Reddy S; O'Brien L; Gonzales C; Skinner M; Knadler MP Clin Pharmacokinet; 2010 May; 49(5):311-21. PubMed ID: 20384393 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and pharmacodynamics of terbutaline in healthy horses. Törneke MK; Ingvast-Larsson JC; Johansson JM; Appelgren LE Am J Vet Res; 2000 Jul; 61(7):761-5. PubMed ID: 10895896 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]